AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2007
Aug 23, 2007
34519_dirs_2007-08-23_31831553-b20b-4fa6-aafb-364b21f4a57b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2007-08-21
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-08-21 | Common Stock, par value $0.10 per share | P | 1000 | $3.68 | Acquired | 405223 | Direct |
| 2007-08-21 | Common Stock, par value $0.10 per share | P | 1000 | $3.74 | Acquired | 406223 | Direct |
| 2007-08-21 | Common Stock, par value $0.10 per share | P | 200 | $3.73 | Acquired | 406423 | Direct |
| 2007-08-21 | Common Stock, par value $0.10 per share | P | 300 | $3.68 | Acquired | 406723 | Direct |
| 2007-08-21 | Common Stock, par value $0.10 per share | P | 300 | $3.66 | Acquired | 407023 | Direct |
| 2007-08-21 | Common Stock, par value $0.10 per share | P | 200 | $3.69 | Acquired | 407223 | Direct |
Footnotes
F1: These shares of common stock were acquired by Arterio, Inc. a corporation owned solely by Mr. Rothschild.
F2: This figure includes 201,510 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23